DCT and health disparities: Insights from a patient advocate

Last updated: August 29, 2024

Basile Trimbur, Medical and Scientific Officer, Patient Engagement Lead at Kayentis, interviews Trishna Bharadia, Health Advocate & Patient Engagement Advisor, on decentralized clinical trials and their impact on health disparities.

Some of the topics covered in this interview are:

Can the gap between the number of patients reaching trials and the study recruitment needs be partially explained by trust issues between patients and the healthcare system? Can DCT help fix this situation? And how?
How would Trishna advise the industry so that we ensure that DCT do not increase the burden and become counter-productive?
Are DCTs a solution to reduce health disparities?

Listen to the full interview:

Trishna Bharadia
Health Advocate & Patient Engagement Advisor

Basile Trimbur
Medical & Scientific Officer, Patient Advocacy Lead

Subscribe to our newsletter

Leveraging the potential of Patient Reported Outcome (PRO) data to...

Gastrointestinal Tract Diseases Research: Moving Towards Patient-Centered Clinical Trials

Turning experience into evidence: PROs in IBD clinical research

BYOD on the rise

Strategies to promote BYOD adoption by clinical study sites

How Kayentis reduces the CO2 emissions of your eCOA projects...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET

In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....